Qianhong Fu, MS

BeOne Medicines Ltd

Poster(s):

• 1401 - Risk of Second Primary Malignancies in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Receiving First-line Therapy: A Real-World Study

• 1410 - Impact of testing for genetic markers on treatment selection and clinical outcomes among patients with chronic lymphocytic leukemia

• 1411 - Outcomes, inequities, and access to front-line preferred therapies for chronic lymphocytic leukemia in the United States: a real-world evidence study

• 1528 - Estimating the Cardiac Deaths Associated with Treating Chronic Lymphocytic Leukemia with Ibrutinib versus Zanubrutinib in the United States